Pharmaceuticals, Biotechnology and Life Sciences
Webcast to be held Monday, September 23, at 8:00 a.m. ET CAMBRIDGE, Mass., Sept. 22, 2024 (GLOBE NEWSWIRE) — Black…
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in…
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific…
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly…
Industry Leaders to Explore Cytek’s Advanced Cell Analysis Solutions at ICCS and ESCCAFREMONT, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) —…
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage…
RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to…
Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel…
BOULDER, Colo., Sept. 18, 2024 (GLOBE NEWSWIRE) — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision…
QIAGEN adds over 100 new validated QIAcuity digital PCR assays for cancer research, inherited genetic disorders, infectious disease surveillance, and…